Last reviewed · How we verify

NCT07376616: EMMA

Cardiovascular Research in EMbarazo and MAternity (EMMA). Study on Heart Rate Variability and Hemodynamic Adaptations During Pregnancy and Postpartum.

Recruiting now Last updated 17 February 2026
What this trial tests

trial testing Assessment of HRV and blood pressure in Pregnancy Related in 242 participants. Currently enrolling.

Timeline
19 May 2025
Primary endpoint
15 December 2027
15 December 2027

Quick facts

Lead sponsorFundacin Biomedica Galicia Sur
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment242
Start date19 May 2025
Primary completion15 December 2027
Estimated completion15 December 2027
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundacin Biomedica Galicia Sur — full company profile →

Who can join

18 and older, female only, with Pregnancy Related or Heart Rate Variation (HRV). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Heart rate variability (HRV) provides a non-invasive assessment of autonomic control of the nervous system over the heart. During pregnancy, the cardiovascular system adapts significantly, affecting HRV and hemodynamics. Studying the relationship between HRV and hemodynamic changes is critical to understanding and monitoring cardiovascular health during pregnancy and postpartum, and predicting potential complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pregnancy Related

Currently open trials in the same condition.

Other Fundacin Biomedica Galicia Sur trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07376616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing